Guidelines

To provide evidence-based recommendations for screening methods and assessments of risk for falls pertaining to patients likely to be seen in...

To review the available empirical evidence and give specific recommendations for the identification of children with autism

To evaluate the clinical effectiveness and cost-effectiveness of natalizumab in the treatment of highly active relapsing remitting multiple sclerosis

To consider the evidence that magnetic resonance imaging (MRI) can prospectively predict the future conversion to clinically definite multiple...

To assist in the use of conventional magnetic resonance imaging (cMRI) for the diagnosis and longitudinal monitoring of patients with multiple...

To assist in the use of conventional magnetic resonance imaging (cMRI) for the diagnosis and longitudinal monitoring of patients with multiple...

To evaluate differences in immunogenicity of interferon-beta (IFN-beta) products

To serve as a guideline for the National Health Service (NHS) in England and Wales

To consider both the evidence leading to the recent Food and Drug Administration (FDA) approval as well as the appropriate clinical role of...

To provide information on the need to vaccinate patients with multiple sclerosis (MS) by evaluating the risk of multiple sclerosis exacerbation...

To consider the clinical utility of disease-modifying agents for multiple sclerosis, including anti-inflammatory, immunomodulatory, and...